Cargando…
Correction: Beran et al. Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic. Pathogens 2020, 9, 1055
Autores principales: | Beran, Jirí, Špajdel, Marian, Katzerová, Věra, Holoušová, Alena, Malyš, Jan, Rousková, Jana Finger, Slíva, Jiří |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465272/ https://www.ncbi.nlm.nih.gov/pubmed/34578255 http://dx.doi.org/10.3390/pathogens10091121 |
Ejemplares similares
-
Inosine Pranobex Significantly Decreased the Case-Fatality Rate among PCR Positive Elderly with SARS-CoV-2 at Three Nursing Homes in the Czech Republic
por: Beran, Jiří, et al.
Publicado: (2020) -
Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course
por: Beran, Jiří, et al.
Publicado: (2021) -
Inosine pranobex is safe and effective for the treatment of subjects with confirmed acute respiratory viral infections: analysis and subgroup analysis from a Phase 4, randomised, placebo-controlled, double-blind study
por: Beran, Jiří, et al.
Publicado: (2016) -
Genotoxicity and Mutagenicity of Inosine Pranobex
por: Tobólska, Sylwia, et al.
Publicado: (2018) -
Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases
por: Sliva, Jiri, et al.
Publicado: (2019)